Loading...
NPI 1720662547 · Cohoes, NY · Community/Retail Pharmacy
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Marras Pharma Corp is a community/retail pharmacy provider located in Cohoes, New York. This profile covers 10 Medicare and 9 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Marras Pharma Corp |
| Address | 217 Remsen St |
| City | Cohoes |
| State | NY |
| ZIP | 12047 |
| Taxonomy | Community/Retail Pharmacy |
| NPI Enumerated | May 7, 2021 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $199.5K |
| Medicare | $113.1K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
10 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 290 | $140 | $41.9K |
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 210 | $80 | $16K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 380 | $40 | $14.7K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 80 | $130 | $10.6K |
| G0008 | Administration of influenza virus vaccine | 350 | $30 | $10.1K |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 690 | $10 | $8.3K |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 80 | $70 | $5.6K |
| 0124A | N/A | 60 | $40 | $2.4K |
| 90674 | This code represents a flu vaccine product that protects against four strains of influenza. It is derived from cell cultures, contains no preservatives or antibiotics, and is administered as a 0.5 mL… | 50 | $30 | $1.7K |
| M0201 | Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patient's home; reported only once per individual home per date of service when such vaccine administration(s)… | 50 | $40 | $1.7K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 10 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
10 rows
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
9 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| T4524 | Adult sized disposable incontinence product, brief/diaper, extra large, each | 490 | $130 | $61.8K |
| T4522 | Adult sized disposable incontinence product, brief/diaper, medium, each | 390 | $100 | $38.5K |
| E0570 | Nebulizer, with compressor | 580 | $60 | $33.8K |
| A4554 | Disposable underpads, all sizes | 490 | $60 | $28.7K |
| T4523 | Adult sized disposable incontinence product, brief/diaper, large, each | 240 | $120 | $27.9K |
| A4670 | Automatic blood pressure monitor | 50 | $50 | $2.4K |
| T4533 | Youth sized disposable incontinence product, brief/diaper, each | 30 | $80 | $2.2K |
| T4535 | Disposable liner/shield/guard/pad/undergarment, for incontinence, each | 50 | $50 | $2.2K |
| E0603 | Breast pump, electric (ac and/or dc), any type | 10 | $160 | $1.9K |
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
9 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| A4554 | Disposable underpads, all sizes | 185 | 270 | 1,960 | $40 | $584.4K |
| T4523 | Adult sized disposable incontinence product, brief/diaper, large, each | 163 | 220 | 1,050 | $80 | $575.4K |
| E0603 | Breast pump, electric (ac and/or dc), any type | 51 | 50 | 1,060 | $150 | $514K |
| T4524 | Adult sized disposable incontinence product, brief/diaper, extra large, each | 110 | 170 | 1,490 | $90 | $464.5K |
| T4535 | Disposable liner/shield/guard/pad/undergarment, for incontinence, each | 180 | 200 | 2,660 | $30 | $442.1K |
| T4522 | Adult sized disposable incontinence product, brief/diaper, medium, each | 135 | 200 | 960 | $50 | $417K |
| T4533 | Youth sized disposable incontinence product, brief/diaper, each | 45 | 50 | 760 | $80 | $200.8K |
| E0570 | Nebulizer, with compressor | 85 | 180 | 470 | $30 | $52.4K |
| A4670 | Automatic blood pressure monitor | 51 | 70 | 180 | $40 | $38.5K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.